SpliceBio
Operator of a biotechnology company intended to develop genetic medicines through protein-splicing gene therapy. The company's platform allows addressing of adeno-associated viruses, both by increasin...
Valuation
$0
Share Price
N/A
Total Raised
$198M
Last Round
N/A